Bruce Japsen, Senior Contributor

Author's posts

Alignment Healthcare Will Expand Medicare Advantage To Lucrative Florida And Texas Markets For 2023

Alignment Healthcare is expanding Medicare Advantage into Florida and Texas for 2023.

Walgreens Won’t Sell U.K. Boots Pharmacies After All

Walgreens Boots Alliance won’t be selling its Boots pharmacies in the United Kingdom following a strategic review of buyers.

Walgreens Launches Clinical Trial Business As FDA Seeks Diversity Of Patients

Walgreens is launching a clinical trial business to increase racial and ethnic diversity for patients in drug research.

As Anthem Rebrands To Elevance, Healthcare Services To Be Named ‘Carelon’

Anthem’s rebrand to Elevance Health will also include the new name of “Carelon” for its healthcare services and “Wellpoint” for certain health plans.

Doctors: Bipartisan Senate Gun Safety Deal ‘Will Safe Lives’

The American Medical Association praised the proposed bipartisan deal reached Sunday in the U.S. Senate to improve gun safety through better background checks and mental health, saying it will save lives.

UnitedHealth Group’s Foundation Commits $100 Million To Health Equity And Diverse Workforce

UnitedHealth Group is committing $100 million over a decade to advance health equity.

South Dakota Voters Reject Effort Aimed At Derailing Medicaid Expansion

South Dakota voters rejected a measure that would have required certain ballot initiatives like Medicaid expansion to pass with 60% support instead of a simple majority.

Becton Dickinson To Buy Pharmacy Automation Firm Parata Systems For $1.5 Billion

Entering the fast-growing pharmacy automation space, Becton Dickinson (BD) will buy Parata Systems from Frazier Healthcare Partners for more than $1.5 billion in cash.

Is Walgreens Sale Of U.K. Boots Pharmacies Finally Near?

Walgreens Boots Alliance sale of its Boots pharmacies in the United Kingdom is apparently near if the latest media reports out of London and India are correct.

Abbott Resumes Baby Formula Production At Michigan Plant

Abbott Laboratories Saturday restarted infant formula production at its Sturgis, Mich., facility after meeting Food and Drug Administration requirements.